These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 11999650)

  • 1. Pulse-spray thrombolysis in acute myocardial infarction caused by thrombotic occlusion of an ectatic coronary artery.
    Tanabe Y; Itoh E; Nakagawa I; Suzuki K
    Circ J; 2002 Feb; 66(2):207-10. PubMed ID: 11999650
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sequential combination thrombolytic therapy for acute myocardial infarction: results of the Pro-Urokinase and t-PA Enhancement of Thrombolysis (PATENT) Trial.
    Zarich SW; Kowalchuk GJ; Weaver WD; Loscalzo J; Sassower M; Manzo K; Byrnes C; Muller JE; Gurewich V
    J Am Coll Cardiol; 1995 Aug; 26(2):374-9. PubMed ID: 7608437
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pulse-spray thrombolysis in acutely obstructed coronary artery in critical situations.
    Saito T; Taniguchi I; Nakamura S; Oka H; Mizuno Y; Noda K; Yamashita S; Oshima S
    Cathet Cardiovasc Diagn; 1997 Jan; 40(1):101-8. PubMed ID: 8993826
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Site-specific intracoronary thrombolysis with urokinase-coated hydrogel balloons: acute and follow-up studies in 95 patients.
    Glazier JJ; Hirst JA; Kiernan FJ; Fram DB; Eldin AM; Primiano CA; Mitchel JF; McKay RG
    Cathet Cardiovasc Diagn; 1997 Jul; 41(3):246-53. PubMed ID: 9213022
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combined revascularization strategy for acute myocardial infarction in patients with intracoronary thrombus: preceding intracoronary thrombolysis and subsequent mechanical angioplasty.
    Ishibashi F; Saito T; Hokimoto S; Noda K; Moriyama Y; Oshima S
    Jpn Circ J; 2001 Apr; 65(4):251-6. PubMed ID: 11316117
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Coronary arterial thrombolysis with low-dose synergistic combinations of recombinant tissue-type plasminogen activator (rt-PA) and recombinant single-chain urokinase-type plasminogen activator (rscu-PA) for acute myocardial infarction.
    Collen D; Van de Werf F
    Am J Cardiol; 1987 Sep; 60(7):431-4. PubMed ID: 3115077
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clot-selective coronary thrombolysis with low-dose synergistic combinations of single-chain urokinase-type plasminogen activator and recombinant tissue-type plasminogen activator. The Pro-Urokinase for Myocardial Infarction Study Group.
    Kirshenbaum JM; Bahr RD; Flaherty JT; Gurewich V; Levine HJ; Loscalzo J; Schumacher RR; Topol EJ; Wahr DW; Braunwald E
    Am J Cardiol; 1991 Dec; 68(17):1564-9. PubMed ID: 1746455
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Thrombolytic agents, urokinase, tissue-type plasminogen activator and pro-urokinase--their routes of administration and dosage: comparison between intracoronary thrombolysis and intravenous coronary thrombolysis].
    Motomiya T
    Nihon Rinsho; 2003 Apr; 61 Suppl 4():441-5. PubMed ID: 12735012
    [No Abstract]   [Full Text] [Related]  

  • 9. [Incidence of residual thrombi following successful thrombolytic therapy in acute myocardial infarct and their significance for the rate of early re-occlusion. A report of a multicenter dose-finding study for thrombolytic therapy with urokinase preactivated natural prourokinase (TCL 598)].
    Gulba DC; Bode C; Topp J; Höpp HW; Westhoff-Bleck M; Rafflenbeul W; Lichtlen PR
    Z Kardiol; 1990 Apr; 79(4):279-85. PubMed ID: 2113330
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Coronary ectasia resulting in thrombotic coronary occlusion after warfarin interruption: a case report].
    Fukuhara S; Takase E; Fujimoto T; Takami Y; Yamamoto K; Nishida T; Morimoto A
    J Cardiol; 2005 Nov; 46(5):195-200. PubMed ID: 16320976
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety and efficacy of extended urokinase infusion plus stent deployment for treatment of obstructed, older saphenous vein grafts.
    Denardo SJ; Morris NB; Rocha-Singh KJ; Curtis GP; Rubenson DS; Teirstein PS
    Am J Cardiol; 1995 Oct; 76(11):776-80. PubMed ID: 7572653
    [TBL] [Abstract][Full Text] [Related]  

  • 12. More rapid, complete, and stable coronary thrombolysis with bolus administration of reteplase compared with alteplase infusion in acute myocardial infarction. RAPID Investigators.
    Smalling RW; Bode C; Kalbfleisch J; Sen S; Limbourg P; Forycki F; Habib G; Feldman R; Hohnloser S; Seals A
    Circulation; 1995 Jun; 91(11):2725-32. PubMed ID: 7758177
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Successful recanalization of an occluded coronary artery by percutaneous coronary intervention, systemic administration of tirofiban, a glycoprotein IIb/IIIa inhibitor, and intracoronary thrombolysis with alteplase.
    Meyners W; Peters S; Trümmel M; Koehler B
    Z Kardiol; 2004 May; 93(5):407-12. PubMed ID: 15160277
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A pilot trial of recombinant desulfatohirudin compared with heparin in conjunction with tissue-type plasminogen activator and aspirin for acute myocardial infarction: results of the Thrombolysis in Myocardial Infarction (TIMI) 5 trial.
    Cannon CP; McCabe CH; Henry TD; Schweiger MJ; Gibson RS; Mueller HS; Becker RC; Kleiman NS; Haugland JM; Anderson JL
    J Am Coll Cardiol; 1994 Apr; 23(5):993-1003. PubMed ID: 8144799
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Retrograde coronary venous administration of recombinant tissue-type plasminogen activator: a unique and effective approach to coronary artery thrombolysis.
    Miyazaki A; Tadokoro H; Drury JK; Rydén L; Haendchen RV; Corday E
    J Am Coll Cardiol; 1991 Aug; 18(2):613-20. PubMed ID: 1906906
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of tirofiban on angiographic morphologic features of high-burden thrombus formation during direct percutaneous coronary intervention and short-term outcomes.
    Yip HK; Wu CJ; Chang HW; Hsieh YK; Fang CY; Chen SM; Chen MC
    Chest; 2003 Sep; 124(3):962-8. PubMed ID: 12970024
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intracoronary thrombolysis in evolving isolated right ventricular infarction.
    Fujita M; Sasayama S; Sakurai T; Nonogi H
    Cathet Cardiovasc Diagn; 1987; 13(1):54-6. PubMed ID: 3815516
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clot-selective coronary thrombolysis with pro-urokinase.
    Loscalzo J; Wharton TP; Kirshenbaum JM; Levine HJ; Flaherty JT; Topol EJ; Ramaswamy K; Kosowsky BD; Salem DN; Ganz P
    Circulation; 1989 Apr; 79(4):776-82. PubMed ID: 2494004
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intracoronary Administration of Thrombolysis for Severe Coronary Artery Ectasia Presenting as an Acute Inferior ST-Segment Elevation Myocardial Infarction.
    Saraswat A; Rahman A; Batra R
    J Invasive Cardiol; 2017 Oct; 29(10):E153. PubMed ID: 28974667
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Significance of a coronary artery with thrombolysis in myocardial infarction grade 2 flow "patency" (outcome in the thrombolysis and angioplasty in myocardial infarction trials). Thrombolysis and Angioplasty in Myocardial Infarction Study Group.
    Lincoff AM; Topol EJ; Califf RM; Sigmon KN; Lee KL; Ohman EM; Rosenschein U; Ellis SG
    Am J Cardiol; 1995 May; 75(14):871-6. PubMed ID: 7732992
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.